CI
GMAB icon

Clal Insurance’s Genmab GMAB Stock Holding History

Clal Insurance’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,000
Closed -$488K – 197
2024
Q3 		$488K Hold
20,000
– – ﹤0.01% 106
2024
Q2 		$503K Hold
20,000
– – 0.01% 104
2024
Q1 		$598K Buy
+20,000
New +$588K 0.01% 111
2022
Q4 		– Sell
-20,000
Closed -$643K – 160
2022
Q3 		$643K Sell
20,000
-28,600
-59% -$1M 0.01% 132
2022
Q2 		$1.58M Buy
48,600
+18,600
+62% +$603K 0.02% 127
2022
Q1 		$1.08M Buy
+30,000
New +$1.03M 0.01% 135

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Clal Insurance's GMAB Position: Q4 2024 in Review

Clal Insurance sold out of Genmab (GMAB) in Q4 2024, closing a stake of 20,000 shares — an estimated $488K sold.

Clal Insurance first reported a position in GMAB in Q1 2022 and held it in 6 quarters. The position peaked at $1.58M in Q2 2022. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • Clal Insurance reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
  • Clal Insurance sold 20,000 Genmab shares in Q4 2024, an estimated $488K.
  • Clal Insurance first reported a position in Genmab in Q1 2022 and held it in 6 quarters.
  • Clal Insurance's Genmab position peaked at $1.58M in Q2 2022.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Clal Insurance's 13F filing for Q4 2024, filed 6 Feb 2025.